Meta Analysis on Effectiveness and Safety of Needling Comparative Drug Prevention for Migraine Treatment

Objective: Systematic evaluation of the preventive efficacy and safety of needling versus drugs against migraines to provide an evidence-based basis for the clinical application of needling. Method: Retrieving Pubmed, The Cochrane library, EMBASE, CBM, VIP, WANFANG Data and CNKI, retrieval time to December 2015, collect needling and A randomized controlled study on drug prevention treatment of migraine. Screening qualified literature and extracting relevant data, the outcome data was divided into two subgroups following follow-up time, 3 to April and 5 to June after randomization. 85 migraine patients.Meta analysis showed that the needling group and drug group were at random Efficacy of treatment after group follow-up from March to April (RR=1.24,95% CI=1.04-1.47, P=0.020), number of migraine days (SMD=-0.30,95% CI=-0.45 to -0.16, P=0.000), degree of headache (SMD=-0.32,95% CI=-0.52 to -0.11, P=0.000) There are statistical differences, the number of migraine days (MD=-0.66,95% CI=-1.18 - -0.13, P=0.010), the degree of headache (SMD=-0.31,95% CI=-0.47 - -0.15, P=0.000) is also statistically significant; and the random grouping followed up 5-June Efficiency of treatment (RR= 1.18,95% CI=0.97 to 1.43, P=0.110) No statistical difference between the two groups; therefore, the acerbic group had more effective treatment, fewer migraine days, less headaches. The adverse reaction rate due to the heterogeneity (P=77%), according to descriptive analysis. Drug Small. Conclusion: Needles relative to drug prevention of migraines Treatment has better therapeutic effects and safety, but more quality trials are needed to further enhance the evidence-based basis.